Patent · US Expired

Uses for indole-3-propionic acids and salts and esters thereof

US6395768B1 · kind B1 · utility

18Cited by
1References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 30, 2000
Grant dateMay 28, 2002
Priority date
Expiry dateMay 30, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The cytotoxic effects of amyloid beta protein on cells are prevented by contacting the cells with an effective amount of an indole-3-propionic acid or a salt or ester thereof. Furthermore, a fibrillogenic disease can be treated in a human subject by administering to the human subject an amount of-an indole-3-propionic acid or a salt or ester thereof effective to prevent or reverse fibrillogenesis. Oxidation in a biological sample can be decreased by contacting the biological sample with an effective amount of an indole-3-propionic acid or a salt or ester thereof. Additionally, diseases or other conditions where free radicals and/or oxidative stress play a role can be treated by administering an effective amount of an indole-3-propionic acid or a salt or ester thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.